Medtronic acquires Sapiens Steering Brain Stimulation for $200 million

Medtronic, Inc. announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation (DBS) technologies for approximately $200 million in an all-cash transaction.The acquisition of Sapiens SBS strengthens Medtronic's capabilities in an important, emerging frontier of medicine - the modulation of brain function. The acquisition exemplifies Medtronic's ongoing investment in innovation as the company strives to become the partner of choice for neurosurgeons and neuroscience centers around the world. Sapiens SBS, located in Eindhoven, The Netherlands, is developing a DBS system that features an advanced DBS lead with 40 individual stimulation points. This advanced system is designed to allow more precise stimulation of the intended target in the brain and may potentially result in reduced procedure time and fewer stimulation-induced side effects.